mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.2 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.2 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.2 |